The health sector’s spending on federal lobbying rose 70% from 2000 to 2020, driven mostly by pharmaceutical and health product manufacturers and providers, according to new research. U.S. healthcare ...

A study was conducted to assess global trends in hypertension awareness, prevalence, treatment, and control between 2000 and 2020.

The pandemic bubble was driven by low rates as much as it was by over enthusiasm, unlike the 2000 tech bubble which occurred against a backdrop of relatively high rates. While IT spending surged ...

The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.